- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06638801
Brain Uptrain to Improve Learning and Development (BUILD)
February 18, 2026 updated by: Colm Travers, University of Alabama at Birmingham
Brain Uptrain to Improve Learning and Development: A Randomized Clinical Trial
The purpose of this study is to see if an early literacy and developmental program in addition to shared reading can increase developmental test scores at 24 months of age.
All caregivers of infants in this study will receive shared reading training.
Half of the caregivers will be trained in an additional coach-led caregiver-implemented early literacy and numeracy program.
Information related to infant development will be collected from parent surveys, medical records, and questionnaires and assessments.
Study Overview
Status
Recruiting
Conditions
Detailed Description
This study will test the hypothesis that in term or late preterm infants who are discharged home from the newborn nursery, a coach-led caregiver-implemented early literacy and developmental program in addition to shared reading, compared with shared reading alone, will increase the Ages and Stages Questionnaire® score at 24 months.
This will be a double blind randomized controlled trial with 1:1 parallel allocation using stratified permuted block design.
Randomization will be stratified by gestational age (≥ 35 to <38 weeks and ≥ 38 weeks).
Randomization of twins and higher orders (when eligible) will be to the same group.
Term and late preterm infants ≥ 35 weeks' gestation admitted to the newborn nursery are eligible for inclusion if they are being discharged home.
We will exclude infants admitted to the NICU, infants with a known syndrome or major malformation, infants in DHR custody, infants enrolled in a competing study, and infants of families with a primary language other than English or Spanish.
All study participants will receive shared reading information at scheduled well-child checks.
Caregivers of infants in the intervention group will receive additional coach-led caregiver-implemented early literacy and developmental program.
We will complete an ASQ-3 online or by telephone at 12 months, 24 months, and 36 months.
We will also measure early literacy at 3 years, 4 years, and 5 years.
The primary outcome will be the ASQ-3 scores at 24 months.
Study Type
Interventional
Enrollment (Estimated)
188
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Colm Travers
- Phone Number: (205) 934-4680
- Email: cptravers@uabmc.edu
Study Contact Backup
- Name: Tamaryn Garcia
- Email: thgarcia@uabmc.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- Recruiting
- University of Alabama at Birmingham
-
Contact:
- Jillian Hamilton, PhD
- Phone Number: 2059344680
- Email: jchamilton@uabmc.edu
-
Contact:
- Colm P Travers, MD
- Phone Number: 2059344680
- Email: cptravers@uabmc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria: inborn at UAB, delivered at more than 35 weeks' gestation, planned for discharge home after initial hospitalization.
-
Exclusion Criteria: a major malformation, a known syndrome, admitted to the NICU, in DHR custody, enrolled in a competing study, and family's primary language is other than English or Spanish.
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Reach Out and Read plus intervention
Reach Out and Read Training in addition to coach-led caregiver-implemented early literacy and developmental program
|
Caregivers will receive training about child brain development in the first 3 years of life.
The training will emphasize the areas of spoken words, physical education, pointer-finger concept, focus and label, reading lessons, and mathematics.
Reach Out and Read parent training
|
|
Active Comparator: Reach out and Read only
Reach Out and Read at well child visits
|
Reach Out and Read parent training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ASQ-3 scores
Time Frame: 24 month well-child visit
|
The total Ages and Stages Questionnaires 3rd Edition score at 24 months
|
24 month well-child visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ASQ-3 scores
Time Frame: 12 month well-child visit
|
The total Ages and Stages Questionnaires 3rd Edition score at 12 months
|
12 month well-child visit
|
|
ASQ-3 scores
Time Frame: 36 month well-child visit
|
The total Ages and Stages Questionnaires 3rd Edition score at 36 months
|
36 month well-child visit
|
|
ASQ scores below -2SD
Time Frame: 12 month well-child visit
|
The proportion of children with Ages and Stages Questionnaires 3rd Edition 2 standard deviations of more below the mean at 12 months
|
12 month well-child visit
|
|
ASQ scores below -2SD
Time Frame: 24 month well-child visit
|
The proportion of children with Ages and Stages Questionnaires 3rd Edition 2 standard deviations of more below the mean at 24 months
|
24 month well-child visit
|
|
ASQ scores below -2SD
Time Frame: 36 month well-child visit
|
The proportion of children with Ages and Stages Questionnaires 3rd Edition 2 standard deviations of more below the mean at 36 months
|
36 month well-child visit
|
|
ASQ scores below -1SD
Time Frame: 12 month well-child visit
|
The proportion of children with Ages and Stages Questionnaires 3rd Edition one standard deviation of more below the mean at 12 months
|
12 month well-child visit
|
|
ASQ scores below -1SD
Time Frame: 24 month well-child visit
|
The proportion of children with Ages and Stages Questionnaires 3rd Edition one standard deviation of more below the mean at 24 months
|
24 month well-child visit
|
|
ASQ scores below -1SD
Time Frame: 36 month well-child visit
|
The proportion of children with Ages and Stages Questionnaires 3rd Edition one standard deviation of more below the mean at 36 months
|
36 month well-child visit
|
|
Literacy Scores
Time Frame: 36 months
|
Get Ready To Read- Revised, McArthur-Bates Communicative Development Inventory, Preschool Language Scales- Fifth Edition scores at 36 months
|
36 months
|
|
Literacy Scores
Time Frame: 48 months
|
Get Ready To Read- Revised, McArthur-Bates Communicative Development Inventory, Preschool Language Scales- Fifth Edition
|
48 months
|
|
Literacy Scores
Time Frame: 60 months
|
Get Ready To Read- Revised, McArthur-Bates Communicative Development Inventory, Preschool Language Scales- Fifth Edition scores at 60 months
|
60 months
|
|
Kindergarten Readiness
Time Frame: 60 months
|
Bracken School Readiness Assessment-Third Edition scores at 60 months
|
60 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Colm P Travers, University of Alabama at Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 18, 2026
Primary Completion (Estimated)
February 18, 2029
Study Completion (Estimated)
June 18, 2031
Study Registration Dates
First Submitted
October 10, 2024
First Submitted That Met QC Criteria
October 10, 2024
First Posted (Actual)
October 15, 2024
Study Record Updates
Last Update Posted (Actual)
February 20, 2026
Last Update Submitted That Met QC Criteria
February 18, 2026
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300013307
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Late Preterm Infant
-
Christiana Care Health ServicesCompletedInfant | Infant, Premature | Infant, Preterm | Infant, LateUnited States
-
University Hospitals Cleveland Medical CenterCompleted
-
Gazi UniversityCompletedSleep | Motor Development | Late Preterm InfantTurkey
-
Turku University HospitalRecruitingPreterm Infant Development | Preterm Infant HealthJapan, South Korea
-
Karadeniz Technical UniversityCompletedPreterm Birth | Preterm Labor | Prenatal Care Late
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedPreterm Infant Development | Preterm Infant Health
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedInfant, Newborn | Infant, Moderate PretermUnited States
-
Medical University of GrazCompleted
-
University Hospital of CologneRecruitingPremature Birth | Preterm Infant Development | Preterm Infant Health | Prematurity ComplicationsGermany